Sofwave Announces FDA Clearance of New Lifting Indications
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
The new indications for the Sofwave system, now FDA cleared, include eyebrow lifts and lifting of lax tissue of the submental and neck areas.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.